Stock screening is commonly deployed by investors to ‘cut through the noise.’ The approach is especially useful when considering the thousands of options to choose from, which can often overwhelm ...

NEW YORK, Sept. 17, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing ...

Think of them as medical detectives, helping doctors detect issues at the genomic level before they become life-threatening ...

Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing ...

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same ...

Israel-based Check-Cap (CHEK) stock jumped about 390% to $3.67 on Monday during pre-market hours of trading, as it announced ...

Allarity has secured exclusive global rights for the development and commercialization of stenoparib, which was originally developed by Eisai Co. Ltd. and was formerly known under the names E7449 and ...

As the Q2 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the immuno ...

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at First Advantage (NASDAQ:FA) and the best ...

Shield is the first and only blood test that has received full FDA approval as a primary screening option for CRC in average-risk adults aged 45 and older and can be ordered by any prescribing ...

The Global X SuperDividend U.S. ETF (DIV) offers a 6.7% yield by focusing on 50 high-yielding, primarily micro-cap U.S.

Nasdaq Verafin's consortium data network is trusted by more than 2,600 financial institutions representing over $10 trillion in collective assets. By leveraging data from more than 725 million ...